查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1315699

泌尿道傳染病檢查市場：按類型、檢測和最終用戶分類 - 全球預測 2023-2030

Urinary Tract Infection Testing Market by Type, Test, End-Use - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球尿路傳染病檢查市場預計將大幅成長，預計到2023年將達到57159萬美元，年複合成長率為10.67%，預計到2030年將達到116786萬美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球泌尿道傳染病檢查市場至關重要。透過檢查業務策略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的特定需求做出明智的資訊。這種進階分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市佔率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、累積和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發地區、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通膨的累積影響。

5.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

6. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1. 泌尿道傳染病檢查的全球市場規模與預測為何？

2.在預測期內，COVID-19 對全球泌尿道傳染病檢查市場的阻礙因素與影響有哪些？

3.在預測期內，全球尿路傳染病檢查市場需要投資哪些產品/細分市場/應用/領域？

4.全球尿路傳染病檢查市場的競爭策略為何？

5. 全球尿路傳染病檢查市場的技術趨勢和法律規範是什麼？

6.全球尿路傳染病檢查市場主要廠商的市佔率為何？

7. 哪些型態和策略性措施被認為適合進入泌尿道傳染病檢查全球市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 促進因素
      • 老年人和女性尿路感染疾病的發生率增加
      • 糖尿病和腎結石的盛行率
      • 政府優惠投資增加快速診斷
    • 抑制因素
      • 產品召回和人們缺乏意識
    • 機會
      • 組合藥物上市增加
      • 新型影像技術和檢查裝置的開發
    • 任務
      • 嚴格的法規要求
  • 市場趨勢
  • COVID-19 的累積影響
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範
  • 客戶客製化

第6章 傳染病檢查市場：依類型

  • 膀胱炎
  • 腎盂腎炎
  • 尿道炎
  • 陰道炎

第7章 傳染病檢查市場按檢測

  • 膀胱鏡檢查泌尿道傳染病檢查
  • 腎臟和膀胱超音波傳染病檢查
  • 實驗室測試
  • 臨床試驗以外的試驗
  • 核掃描泌尿道傳染病檢查
  • 泌尿道傳染病檢查
  • 尿液檢查 泌尿道傳染病檢查
  • 尿培養尿路傳染病檢查
  • 排尿性造影(VCUG) 泌尿道傳染病檢查

第8章 傳染病檢查市場：依最終用途

  • 責任護理組織
  • 全科醫生
  • 醫院急診部門
  • 醫院實驗室
  • 參考實驗室
  • 緊急護理
  • 泌尿系統
  • 泌尿系統

第9章 美洲泌尿道傳染病檢查市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章 亞太泌尿道傳染病檢查市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲泌尿道傳染病檢查市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭形勢

  • FPNV定位矩陣
  • 市佔率分析：主要企業
  • 競爭情境分析：主要企業

第13章上市公司名單

第14章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-7C50F27396FF

The Global Urinary Tract Infection Testing Market is forecasted to grow significantly, with a projected USD 571.59 million in 2023 at a CAGR of 10.67% and expected to reach a staggering USD 1,167.86 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Urinary Tract Infection Testing Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Urinary Tract Infection Testing Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Type, market is studied across Cystitis, Pyelonephritis, Urethritis, and Vaginitis. The Pyelonephritis is projected to witness significant market share during forecast period.

Based on Test, market is studied across Cystoscopy Urinary Tract Infection Testing, Kidney & Bladder Ultrasound Urinary Tract Infection Testing, Laboratory Test, Non-Laboratory Test, Nuclear Scans Urinary Tract Infection Testing, Susceptibility Urinary Tract Infection Testing, Urinalysis Urinary Tract Infection Testing, Urine Culture Urinary Tract Infection Testing, and Voiding Cystourethrogram (VCUG) Urinary Tract Infection Testing. The Nuclear Scans Urinary Tract Infection Testing is projected to witness significant market share during forecast period.

Based on End-Use, market is studied across Accountable Care Organizations, General Practitioners, Hospital Emergency Departments, Hospital Laboratories, Reference Laboratories, Urgent Care, Urogynecologists, and Urologists. The Urgent Care is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Urinary Tract Infection Testing Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Urinary Tract Infection Testing Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Urinary Tract Infection Testing Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Urinary Tract Infection Testing Market?

4. What is the competitive strategic window for opportunities in the Global Urinary Tract Infection Testing Market?

5. What are the technology trends and regulatory frameworks in the Global Urinary Tract Infection Testing Market?

6. What is the market share of the leading vendors in the Global Urinary Tract Infection Testing Market?

7. What modes and strategic moves are considered suitable for entering the Global Urinary Tract Infection Testing Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Urinary Tract Infection Testing Market, by Type, 2022 vs 2030
  • 4.3. Urinary Tract Infection Testing Market, by Test, 2022 vs 2030
  • 4.4. Urinary Tract Infection Testing Market, by End-Use, 2022 vs 2030
  • 4.5. Urinary Tract Infection Testing Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidence of urinary tract infections among geriartic and women
      • 5.1.1.2. Prevalence of diabetes and kidney stones
      • 5.1.1.3. Favorable investments by the government to increase rapid diagnostics
    • 5.1.2. Restraints
      • 5.1.2.1. Product recall and lack of awareness among the people
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing launch of combination drugs
      • 5.1.3.2. Development of new imaging technologies and testing devices
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory requirements
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Urinary Tract Infection Testing Market, by Type

  • 6.1. Introduction
  • 6.2. Cystitis
  • 6.3. Pyelonephritis
  • 6.4. Urethritis
  • 6.5. Vaginitis

7. Urinary Tract Infection Testing Market, by Test

  • 7.1. Introduction
  • 7.2. Cystoscopy Urinary Tract Infection Testing
  • 7.3. Kidney & Bladder Ultrasound Urinary Tract Infection Testing
  • 7.4. Laboratory Test
  • 7.5. Non-Laboratory Test
  • 7.6. Nuclear Scans Urinary Tract Infection Testing
  • 7.7. Susceptibility Urinary Tract Infection Testing
  • 7.8. Urinalysis Urinary Tract Infection Testing
  • 7.9. Urine Culture Urinary Tract Infection Testing
  • 7.10. Voiding Cystourethrogram (VCUG) Urinary Tract Infection Testing

8. Urinary Tract Infection Testing Market, by End-Use

  • 8.1. Introduction
  • 8.2. Accountable Care Organizations
  • 8.3. General Practitioners
  • 8.4. Hospital Emergency Departments
  • 8.5. Hospital Laboratories
  • 8.6. Reference Laboratories
  • 8.7. Urgent Care
  • 8.8. Urogynecologists
  • 8.9. Urologists

9. Americas Urinary Tract Infection Testing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Urinary Tract Infection Testing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Urinary Tract Infection Testing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. URINARY TRACT INFECTION TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. URINARY TRACT INFECTION TESTING MARKET SIZE, 2022 VS 2030
  • FIGURE 3. URINARY TRACT INFECTION TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
  • FIGURE 5. URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2022 VS 2030 (%)
  • FIGURE 6. URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2022 VS 2030 (%)
  • FIGURE 7. URINARY TRACT INFECTION TESTING MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. URINARY TRACT INFECTION TESTING MARKET DYNAMICS
  • FIGURE 9. URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. URINARY TRACT INFECTION TESTING MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. URINARY TRACT INFECTION TESTING MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. URINARY TRACT INFECTION TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. URINARY TRACT INFECTION TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 5. URINARY TRACT INFECTION TESTING MARKET SIZE, BY CYSTITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. URINARY TRACT INFECTION TESTING MARKET SIZE, BY PYELONEPHRITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. URINARY TRACT INFECTION TESTING MARKET SIZE, BY URETHRITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. URINARY TRACT INFECTION TESTING MARKET SIZE, BY VAGINITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 10. URINARY TRACT INFECTION TESTING MARKET SIZE, BY CYSTOSCOPY URINARY TRACT INFECTION TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. URINARY TRACT INFECTION TESTING MARKET SIZE, BY KIDNEY & BLADDER ULTRASOUND URINARY TRACT INFECTION TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. URINARY TRACT INFECTION TESTING MARKET SIZE, BY LABORATORY TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. URINARY TRACT INFECTION TESTING MARKET SIZE, BY NON-LABORATORY TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. URINARY TRACT INFECTION TESTING MARKET SIZE, BY NUCLEAR SCANS URINARY TRACT INFECTION TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. URINARY TRACT INFECTION TESTING MARKET SIZE, BY SUSCEPTIBILITY URINARY TRACT INFECTION TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. URINARY TRACT INFECTION TESTING MARKET SIZE, BY URINALYSIS URINARY TRACT INFECTION TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. URINARY TRACT INFECTION TESTING MARKET SIZE, BY URINE CULTURE URINARY TRACT INFECTION TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. URINARY TRACT INFECTION TESTING MARKET SIZE, BY VOIDING CYSTOURETHROGRAM (VCUG) URINARY TRACT INFECTION TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 20. URINARY TRACT INFECTION TESTING MARKET SIZE, BY ACCOUNTABLE CARE ORGANIZATIONS , BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. URINARY TRACT INFECTION TESTING MARKET SIZE, BY GENERAL PRACTITIONERS , BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. URINARY TRACT INFECTION TESTING MARKET SIZE, BY HOSPITAL EMERGENCY DEPARTMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. URINARY TRACT INFECTION TESTING MARKET SIZE, BY HOSPITAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. URINARY TRACT INFECTION TESTING MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. URINARY TRACT INFECTION TESTING MARKET SIZE, BY URGENT CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. URINARY TRACT INFECTION TESTING MARKET SIZE, BY UROGYNECOLOGISTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. URINARY TRACT INFECTION TESTING MARKET SIZE, BY UROLOGISTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 58. INDIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 61. INDONESIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. INDONESIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 63. INDONESIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 64. JAPAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. JAPAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 66. JAPAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 67. MALAYSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. MALAYSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 69. MALAYSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 70. PHILIPPINES URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. PHILIPPINES URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 72. PHILIPPINES URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 73. SINGAPORE URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. SINGAPORE URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 75. SINGAPORE URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 76. SOUTH KOREA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. SOUTH KOREA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 78. SOUTH KOREA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 79. TAIWAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. TAIWAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 81. TAIWAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 82. THAILAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. THAILAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 84. THAILAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 85. VIETNAM URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. VIETNAM URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 87. VIETNAM URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 92. DENMARK URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. DENMARK URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 94. DENMARK URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 95. EGYPT URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. EGYPT URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 97. EGYPT URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 98. FINLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. FINLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 100. FINLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 101. FRANCE URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. FRANCE URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 103. FRANCE URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 104. GERMANY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. GERMANY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 106. GERMANY URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 107. ISRAEL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. ISRAEL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 109. ISRAEL URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 110. ITALY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. ITALY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 112. ITALY URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 113. NETHERLANDS URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. NETHERLANDS URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 115. NETHERLANDS URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 116. NIGERIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. NIGERIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 118. NIGERIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 119. NORWAY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. NORWAY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 121. NORWAY URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 122. POLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. POLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 124. POLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 125. QATAR URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. QATAR URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 127. QATAR URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 128. RUSSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. RUSSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 130. RUSSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 131. SAUDI ARABIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SAUDI ARABIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 133. SAUDI ARABIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 134. SOUTH AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SOUTH AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 136. SOUTH AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 137. SPAIN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. SPAIN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 139. SPAIN URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 140. SWEDEN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. SWEDEN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 142. SWEDEN URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 143. SWITZERLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. SWITZERLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 145. SWITZERLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 146. TURKEY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. TURKEY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 148. TURKEY URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED ARAB EMIRATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. UNITED ARAB EMIRATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 151. UNITED ARAB EMIRATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 152. UNITED KINGDOM URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. UNITED KINGDOM URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 154. UNITED KINGDOM URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 155. URINARY TRACT INFECTION TESTING MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 156. URINARY TRACT INFECTION TESTING MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 157. URINARY TRACT INFECTION TESTING MARKET LICENSE & PRICING